Tuse D, Malm M, Tamminen K, Diessner A, et al. Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plants. Vaccine 2022 Jan 18. pii: S0264-410X(22)00022.
PMID: 35063285